Effectiveness and Tolerability of Eptinezumab
NCT06409845
Brain Diseases, Central Nervous System Diseases
Florence, Italy
View Trial DetailsNCT Number: NCT03536936
The aim of the study is to retrospectively evaluate brain perfusion and oxygenation in acute migraine attacks. Magnetic resonance perfusion and susceptibility weighted imaging are the technics to measure perfusion and oxygenation respectively.
Looking for future studies?
Notify Me6 year–80 year
All sexes
Observational
The aim of the study is to demonstrate a possible correlation between areas of hypoperfusion and prominent cortical veins during migraine attacks.
These focal ares of altered vascular supply of the brain will be evaluated for correlation with topograhy of symptoms.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
final clinical diagnosis of migraine
Exclusion criteria
brain tumors, seizures/epilepsy, confirmed cerebral infarct from cerebral atery occlusion, sinus vein thrombosis;
Time frame: Patients, who are admitted to hospital, undergo magnetic resonance imaging within 5 days of migraine attack; time frame: symptoms to imaging : 5 days;
Focal cerebral hypoperfusion and elevated oxygenation in acute migraine attack, measured with visual scores on imaging, using a consensus between two readers
Insel Gruppe AG, University Hospital Bern
Other
Acronym: OPAMA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06409845
Brain Diseases, Central Nervous System Diseases
Florence, Italy
View Trial DetailsNCT05903040
Brain Diseases, Central Nervous System Diseases
Florence, Italy
View Trial DetailsNCT06051604
Brain Diseases, Central Nervous System Diseases
New York, United States
View Trial DetailsNCT04940390
Brain Diseases, Central Nervous System Diseases
Chandler, Arizona, United States
View Trial Details